We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01508026
Recruitment Status : Completed
First Posted : January 11, 2012
Last Update Posted : April 25, 2014
Sponsor:
Information provided by (Responsible Party):
Forest Laboratories

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2013
  Study Completion Date : May 2013
  Certification or Request for Extension to Delay Results Submission: March 28, 2014